Description of the clinical outcomes of hospitalized patients with heart failure with different serum potassium levels

Trial Identifier: D9484R00002
Sponsor: AstraZeneca
Collaborator:
Zhongshan Hospital, Fudan University
Start Date: November 2021
Primary Completion Date: July 2022
Study Completion Date: July 2022
Condition: Congestive Heart Failure; Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China, Shanghai Shanghai, China